Showing 1 - 20 results of 21 for search 'Juan Sierra Madero', query time: 0.47s Refine Results
  1. 1
    High prevalence of late diagnosis of HIV in Mexico during the HAART era

    High prevalence of late diagnosis of HIV in Mexico during the HAART era by Brenda Crabtree-Ramírez, Yanink Caro-Vega, Francisco Belaunzarán-Zamudio, Juan Sierra-Madero

    Published 2012-10-01
    Get full text
    Article
  2. 2
    Prevención y control de la infección por coronavirus SARS-CoV-2 (Covid-19) en unidades de hemodiálisis

    Prevención y control de la infección por coronavirus SARS-CoV-2 (Covid-19) en unidades de hemodiálisis by Olynka Vega-Vega, Mauricio Arvizu-Hernández, José Guillermo Domínguez-Cherit, Juan Sierra-Madero, Ricardo Correa-Rotter

    Published 2020-05-01
    Get full text
    Article
  3. 3
    Did Universal Access to ARVT in Mexico Impact Suboptimal Antiretroviral Prescriptions?

    Did Universal Access to ARVT in Mexico Impact Suboptimal Antiretroviral Prescriptions? by Yanink Caro-Vega, Patricia Volkow, Juan Sierra-Madero, M. Arantxa Colchero, Brenda Crabtree-Ramírez, Sergio Bautista-Arredondo

    Published 2013-01-01
    Get full text
    Article
  4. 4
    Clinical outcomes and risk factors for immune recovery and all‐cause mortality in Latin Americans living with HIV with virological success: a retrospective cohort study

    Clinical outcomes and risk factors for immune recovery and all‐cause mortality in Latin Americans living with HIV with virological success: a retrospective cohort study by Gabriel Castillo‐Rozas, Shengxin Tu, Paula Mendes Luz, Fernando Mejia, Juan Sierra‐Madero, Vanessa Rouzier, Bryan E. Shepherd, Claudia P. Cortes

    Published 2024-03-01
    Get full text
    Article
  5. 5
    Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy‐years

    Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy‐years by Viviane D Lima, Juan Sierra‐Madero, Zunyou Wu, Joel Singer, Evan Wood, Mark W Hull, Paul Richard Harrigan, Julio SG Montaner

    Published 2014-01-01
    Get full text
    Article
  6. 6
    EFICÁCIA DURADOURA DE DOLUTEGRAVIR (DTG) E LAMIVUDINA (3 TC) PARA TERAPIA ANTIRETROVIRAL DE ADULTOS COM INFECÇÃO POR HIV‐1 SEM TRATAMENTO PRÉVIO ‐ RESULTADO DE 3 ANOS DOS ESTUDOS GEMINI

    EFICÁCIA DURADOURA DE DOLUTEGRAVIR (DTG) E LAMIVUDINA (3 TC) PARA TERAPIA ANTIRETROVIRAL DE ADULTOS COM INFECÇÃO POR HIV‐1 SEM TRATAMENTO PRÉVIO ‐ RESULTADO DE 3 ANOS DOS ESTUDOS G... by Pedro Cahn, Juan Sierra Madero, José Ramón Arribas, Jörg Sievers, Choy Man, Rimgaile Urbaityte, Mark Underwood, Jean Andre Van Wyk, Kimberly Smith, Roberto Zajdenverg

    Published 2021-01-01
    Get full text
    Article
  7. 7
    Estimating the Impact of Earlier ART Initiation and Increased Testing Coverage on HIV Transmission among Men Who Have Sex with Men in Mexico using a Mathematical Model.

    Estimating the Impact of Earlier ART Initiation and Increased Testing Coverage on HIV Transmission among Men Who Have Sex with Men in Mexico using a Mathematical Model. by Yanink Caro-Vega, Carlos del Rio, Viviane Dias Lima, Malaquias Lopez-Cervantes, Brenda Crabtree-Ramirez, Sergio Bautista-Arredondo, M Arantxa Colchero, Juan Sierra-Madero

    Published 2015-01-01
    Get full text
    Article
  8. 8
    Impact of treatment adherence on efficacy of dolutegravir plus lamivudine and dolutegravir plus tenofovir disoproxil fumarate/emtricitabine: pooled analysis of the GEMINI-1 and GEMINI-2 clinical studies

    Impact of treatment adherence on efficacy of dolutegravir plus lamivudine and dolutegravir plus tenofovir disoproxil fumarate/emtricitabine: pooled analysis of the GEMINI-1 and GEM... by Mounir Ait-Khaled, Juan Sierra Madero, Vicente Estrada, Roberto Gulminetti, Debbie Hagins, Hung-Chin Tsai, Choy Man, Jörg Sievers, Richard Grove, Andrew Zolopa, Brian Wynne, Jean van Wyk

    Published 2021-12-01
    Get full text
    Article
  9. 9
    Cross-sectional analysis of late HAART initiation in Latin America and the Caribbean: late testers and late presenters.

    Cross-sectional analysis of late HAART initiation in Latin America and the Caribbean: late testers and late presenters. by Brenda Crabtree-Ramírez, Yanink Caro-Vega, Bryan E Shepherd, Firas Wehbe, Carina Cesar, Claudia Cortés, Denis Padgett, Serena Koenig, Eduardo Gotuzzo, Pedro Cahn, Catherine McGowan, Daniel Masys, Juan Sierra-Madero, CCASAnet Team

    Published 2011-01-01
    Get full text
    Article
  10. 10
    Pilot, randomized study assessing safety, tolerability and efficacy of simplified LPV/r maintenance therapy in HIV patients on the 1 PI-based regimen.

    Pilot, randomized study assessing safety, tolerability and efficacy of simplified LPV/r maintenance therapy in HIV patients on the 1 PI-based regimen. by Pedro Cahn, Julio Montaner, Patrice Junod, Patricia Patterson, Alejandro Krolewiecki, Jaime Andrade-Villanueva, Isabel Cassetti, Juan Sierra-Madero, Arnaldo David Casiró, Raul Bortolozzi, Sergio Horacio Lupo, Nadia Longo, Emmanouil Rampakakis, Nabil Ackad, John S Sampalis

    Published 2011-01-01
    Get full text
    Article
  11. 11
    Late-onset opportunistic infections while receiving anti-retroviral therapy in Latin America: burden and risk factors

    Late-onset opportunistic infections while receiving anti-retroviral therapy in Latin America: burden and risk factors by Isaac Núñez, Brenda Crabtree-Ramirez, Bryan E. Shepherd, Timothy R. Sterling, Pedro Cahn, Valdiléa G. Veloso, Claudia P Cortes, Denis Padgett, Eduardo Gotuzzo, Juan Sierra-Madero, Catherine C. McGowan, Anna K. Person, Yanink Caro-Vega

    Published 2022-09-01
    Get full text
    Article
  12. 12
    Tuberculosis treatment intermittency in the continuation phase and mortality in HIV-positive persons receiving antiretroviral therapy

    Tuberculosis treatment intermittency in the continuation phase and mortality in HIV-positive persons receiving antiretroviral therapy by Brenda Crabtree-Ramirez, Cathy A. Jenkins, Bryan E. Shepherd, Karu Jayathilake, Valdilea G. Veloso, Gabriela Carriquiry, Eduardo Gotuzzo, Claudia P. Cortes, Dennis Padgett, Catherine McGowan, Juan Sierra-Madero, Serena Koenig, Jean W. Pape, Timothy R. Sterling, the CCASAnet Region of IeDEA

    Published 2022-04-01
    Get full text
    Article
  13. 13
    Effect of Tocilizumab in Mortality among Patients with Severe and Critical Covid-19: Experience in a Third-Level Medical Center

    Effect of Tocilizumab in Mortality among Patients with Severe and Critical Covid-19: Experience in a Third-Level Medical Center by Bernardo A. Martinez-Guerra, Nereyda A. de-León-Cividanes, Karla M. Tamez-Torres, Carla M. Román-Montes, Sandra Rajme-López, Edgar Ortiz-Brizuela, Carlos A. Aguilar-Salinas, Juan Sierra-Madero, José Sifuentes-Osornio, Alfredo Ponce-de-León, María F. González-Lara

    Published 2022-01-01
    Get full text
    Article
  14. 14
    Add-on Pyridostigmine Enhances CD4+ T-Cell Recovery in HIV-1-Infected Immunological Non-Responders: A Proof-of-Concept Study

    Add-on Pyridostigmine Enhances CD4+ T-Cell Recovery in HIV-1-Infected Immunological Non-Responders: A Proof-of-Concept Study by Sergio I. Valdés-Ferrer, Sergio I. Valdés-Ferrer, Sergio I. Valdés-Ferrer, José C. Crispín, Pablo F. Belaunzarán-Zamudio, Carlos A. Rodríguez-Osorio, Carlos A. Rodríguez-Osorio, Bernardo Cacho-Díaz, Bernardo Cacho-Díaz, Jorge Alcocer-Varela, Carlos Cantú-Brito, Juan Sierra-Madero

    Published 2017-10-01
    Get full text
    Article
  15. 15
    Time to HAART Initiation after Diagnosis and Treatment of Opportunistic Infections in Patients with AIDS in Latin America.

    Time to HAART Initiation after Diagnosis and Treatment of Opportunistic Infections in Patients with AIDS in Latin America. by Brenda Crabtree-Ramírez, Yanink Caro-Vega, Bryan E Shepherd, Beatriz Grinsztejn, Marcelo Wolff, Claudia P Cortes, Denis Padgett, Gabriela Carriquiry, Valeria Fink, Karu Jayathilake, Anna K Person, Catherine McGowan, Juan Sierra-Madero, Caribbean, Central and South America Network for HIV Epidemiology (CCASAnet), of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Program

    Published 2016-01-01
    Get full text
    Article
  16. 16
    Duration of anti-tuberculosis therapy and timing of antiretroviral therapy initiation: association with mortality in HIV-related tuberculosis.

    Duration of anti-tuberculosis therapy and timing of antiretroviral therapy initiation: association with mortality in HIV-related tuberculosis. by Claudia P Cortes, Firas H Wehbe, Catherine C McGowan, Bryan E Shepherd, Stephany N Duda, Cathy A Jenkins, Elsa Gonzalez, Gabriela Carriquiry, Mauro Schechter, Denis Padgett, Carina Cesar, Juan Sierra Madero, Jean W Pape, Daniel R Masys, Timothy R Sterling, Caribbean, Central American, South American Network for HIV Research of the International Epidemiologic Databases to Evaluate AIDS

    Published 2013-01-01
    Get full text
    Article
  17. 17
    A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol

    A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortal... by Sergio Fragoso-Saavedra, David A. Iruegas-Nunez, Alejandro Quintero-Villegas, H. Benjamín García-González, Isaac Nuñez, Sergio L. Carbajal-Morelos, Belem M. Audelo-Cruz, Sarahi Arias-Martínez, Yanink Caro-Vega, Juan José Calva, Verónica Luqueño-Martínez, Alejandra González-Duarte, Brenda Crabtree-Ramírez, José C. Crispín, Juan Sierra-Madero, Pablo F. Belaunzarán-Zamudio, Sergio I. Valdés-Ferrer

    Published 2020-10-01
    Get full text
    Article
  18. 18
    Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin America.

    Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin America. by Carina Cesar, Bryan E Shepherd, Alejandro J Krolewiecki, Valeria I Fink, Mauro Schechter, Suely H Tuboi, Marcelo Wolff, Jean W Pape, Paul Leger, Denis Padgett, Juan Sierra Madero, Eduardo Gotuzzo, Omar Sued, Catherine C McGowan, Daniel R Masys, Pedro E Cahn, Caribbean, Central and South America Network for HIV Research (CCASAnet) Collaboration of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Program

    Published 2010-06-01
    Get full text
    Article
  19. 19
    Health outcomes among HIV‐positive Latinos initiating antiretroviral therapy in North America versus Central and South America

    Health outcomes among HIV‐positive Latinos initiating antiretroviral therapy in North America versus Central and South America by Carina Cesar, John R Koethe, Mark J Giganti, Peter Rebeiro, Keri N Althoff, Sonia Napravnik, Angel Mayor, Beatriz Grinsztejn, Marcelo Wolff, Denis Padgett, Juan Sierra‐Madero, Eduardo Gotuzzo, Timothy R Sterling, James Willig, Julie Levison, Mari Kitahata, Maria C Rodriguez‐Barradas, Richard D Moore, Catherine McGowan, Bryan E Shepherd, Pedro Cahn, for the Caribbean, Central and South America Network for HIV epidemiology (CCASAnet) and the North American AIDS Cohort Collaboration on Research and Design (NA‐ACCORD)

    Published 2016-01-01
    Get full text
    Article
  20. 20
    A picture is worth a thousand words: maps of HIV indicators to inform research, programs, and policy from NA‐ACCORD and CCASAnet clinical cohorts

    A picture is worth a thousand words: maps of HIV indicators to inform research, programs, and policy from NA‐ACCORD and CCASAnet clinical cohorts by Keri N Althoff, Peter F Rebeiro, David B Hanna, Denis Padgett, Michael A Horberg, Beatriz Grinsztejn, Alison G Abraham, Robert Hogg, M John Gill, Marcelo J Wolff, Angel Mayor, Anita Rachlis, Carolyn Williams, Timothy R Sterling, Mari M Kitahata, Kate Buchacz, Jennifer E Thorne, Carina Cesar, Fernando M Cordero, Sean B Rourke, Juan Sierra‐Madero, Jean W Pape, Pedro Cahn, Catherine McGowan, for the North American Aids Cohort Collaboration on Research and Design (na‐Accord) and the Caribbean, Central and the South America Network for Hiv Epidemiology (ccasanet)

    Published 2016-01-01
    Get full text
    Article

Search Tools: